Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
PARAMETERS | Trading Specifications per Account Type | |||||
---|---|---|---|---|---|---|
PREMIUM | ZERO | PRO | ||||
Spreads as low as | 0.22 | 0.22 | 0.22 | |||
Size of 1 lot | 100 shares | 100 shares | 100 shares | |||
Minimum Contract size, lots | 0.01 | 0.01 | 0.01 | |||
Maximum Contract size, lots | 50 | 50 | 50 | |||
Tick value per 1 lot | 1 USD | 1 USD | 1 USD | |||
Volume limitation | 50 lots per account | 50 lots per account | 50 lots per account | |||
Margin requirement | 4% | 4% | 4% | |||
Minimum Price Increment | 0.01 | 0.01 | 0.01 | |||
Limit and Stop Levels | 15.0 | 15.0 | 15.0 | |||
Negative balance protection | Yes | Yes | Yes | |||
Swap free days allowance | 0 | 0 | 0 |